| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10,584 | 10,469 | 12,726 | 6,157 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 10,584 | 10,469 | 12,726 | 6,157 | | | Operating Expenses | | Research Development | 16,247 | 18,540 | 18,567 | 15,563 | | Selling General and Administrative | 1,511 | 2,321 | 2,913 | 2,051 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
| 258 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,174) | (10,392) | (8,754) | (11,715) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 155 | 98 | 416 | | Earnings Before Interest And Taxes | (7,040) | (10,237) | (8,656) | (11,299) | | Interest Expense |
-
|
-
|
-
| 594 | | Income Before Tax | (7,040) | (10,237) | (8,656) | (11,893) | | Income Tax Expense | (238) | (1,650) | (748) |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,802) | (8,587) | (7,908) | (11,893) | | | Non-recurring Events | | Discontinued Operations | 608 | (1,094) | 22,667 | 4,117 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,194) | (9,681) | 14,759 | (7,776) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,194) | ($9,681) | $14,759 | ($7,776) |
|
0.06% Nasdaq 
0.02 (0.27%) 
Income Statement
